Skip to main content

Rylaze 10 mg/0.5 mL injection Images

Generic Name: asparaginase erwinia chrysanthemi

This medication has been identified as Rylaze 10 mg/0.5 mL injection. It is supplied by Jazz Pharmaceuticals plc.

Rylaze is used in the treatment of Acute Lymphoblastic Leukemia and belongs to the drug class miscellaneous antineoplastics. Risk cannot be ruled out during pregnancy. Rylaze 10 mg/0.5 mL injection is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Rylaze 10 mg/0.5 mL injection medicine

Rylaze

Generic Name
asparaginase erwinia chrysanthemi
Strength
10 mg/0.5 mL injection
Availability
Prescription only
Drug Class
Miscellaneous antineoplastics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Jazz Pharmaceuticals plc
National Drug Code (NDC)
68727-0900

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.